Dec Group
Life Sciences
End-to-end solution provider for integrated containment processes for hazardous materials
Überblick
Dec Group is a global leader in high-containment processing technologies, serving the pharmaceutical, chemical, and specialty industries. The company offers a comprehensive range of solutions, including powder handling, containment, aseptic filling, and continuous processing technologies. With a presence in over 60 countries and a strong focus on innovation, Dec is a trusted partner for blue-chip clients worldwide.
Sector
Life Sciences
Investment
2020
Location
Ecublens (CH)
Status
Active
Capiton invested alongside the founders of Dec Group, who made a substantial reinvestment and were seeking a partner to drive growth through capacity expansion and acquisitions
Investment Thesis
- Leading market position paired with an innovative product portfolio underlined by favorable market trends
- Superior technology, allowing DEC to expand its product portfolio to cover various process steps
- Organic growth opportunities through international expansion and the development of profitable and recurring after-sales business
- Buy and build opportunities due to smaller players with interesting technologies that could benefit from Dec’s global reach
Value Creation
- Expansion of technology and product portfolio via four acquisitions, developing Dec from a component to a true end-to-end solution provider
- Significant capacity expansion at the Polish facility to facilitate growth
- Geographic expansion with focus on US and India/Asia via organic and inorganic actions
Sie haben Fragen?
Ihre Ansprechpartner zum Thema
Jonathan Lerman
Investment Director